ENDRA Life Sciences Inc.
NDRANasdaqCIK 1681682HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0816:15 ET | SCHEDULE 13D | Ownership report, active investor | 0001477932-26-006128 |
| 2026-10-0117:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-105899 |
| 2026-08-1716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090747 |
| 2026-08-1416:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090027 |
| 2026-07-0906:08 ET | 8-K | 8.01 Other events | 0001213900-26-076526 |
| 2026-06-2921:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-073318 |
| 2026-06-2606:10 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-072268 |
| 2026-06-2509:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-071804 |
| 2026-05-2806:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-061701 |
| 2026-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057680 |
| 2026-04-2108:00 ET | 8-K | 3.01 Delisting notice | 0001213900-26-045885 |
| 2026-03-3117:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-037617 |
| 2026-03-3116:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-037497 |
| 2026-03-2509:21 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-033878 |
| 2025-12-1520:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-121374 |
| 2025-11-2816:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-116103 |
| 2025-11-2616:30 ET | SCHEDULE 13D | Ownership report, active investor | 0000898432-25-000936 |
| 2025-11-1416:27 ET | 8-K | 8.01 Other events | 0001213900-25-110897 |
| 2025-11-1416:24 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110887 |
| 2025-10-3021:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-103707 |
| 2025-10-2807:01 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001654954-25-012254 |
| 2025-10-2308:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-012084 |
| 2025-10-1517:01 ET | 8-K/A | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.08 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-011825 |
| 2025-10-1509:09 ET | 8-K | 9.01 Financial statements and exhibits | 0001654954-25-011797 |
| 2025-08-1416:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001654954-25-009643 |
| 2025-07-2509:28 ET | S-1/A | Registration statement, amended | 0001654954-25-008477 |
| 2025-07-2309:05 ET | 8-K | 8.01 Other events | 0001654954-25-008318 |
| 2025-07-1609:05 ET | S-1/A | Registration statement, amended | 0001654954-25-008117 |
| 2025-07-0916:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-007893 |
| 2025-07-0908:56 ET | S-1 | Registration statement | 0001654954-25-007870 |
| 2025-06-1108:20 ET | 8-K | 7.01 Regulation FD disclosure | 0001654954-25-006811 |
| 2025-05-3008:00 ET | 8-K | 3.01 Delisting notice | 0001654954-25-006282 |
| 2025-05-1516:59 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001654954-25-005770 |
| 2025-05-1516:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-005768 |
| 2025-04-0718:42 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001654954-25-003937 |
| 2025-03-3108:51 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001654954-25-003612 |
| 2025-03-3108:49 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-003611 |
| 2024-11-2208:42 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-014793 |
| 2024-11-2117:14 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-09-30 | 0001654954-24-014771 |
| 2024-11-1917:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001654954-24-014670 |
| 2024-11-1516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-014547 |
| 2024-11-0508:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-24-013720 |
| 2024-10-2916:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001654954-24-013446 |
| 2024-09-1617:28 ET | DEF 14A | Proxy statementPeriod 2024-09-06 | 0001654954-24-011972 |
| 2024-08-2817:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-011213 |
| 2024-08-2316:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-011072 |
| 2024-08-1616:10 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010837 |
| 2024-08-1416:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001654954-24-010642 |
| 2024-08-1309:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010399 |
| 2024-08-0908:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-010213 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.